177 related articles for article (PubMed ID: 32111358)
1. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration.
Chandrasekhar J; Kalkman DN; Aquino MB; Sartori S; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Schee A; Munawar M; Gerber RT; Yan BP; Tejedor P; Kala P; Liew HB; Lee M; Baber U; Vogel B; Dangas GD; Colombo A; de Winter RJ; Mehran R; ;
Int J Cardiol; 2020 May; 307():17-23. PubMed ID: 32111358
[TBL] [Abstract][Full Text] [Related]
2. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
Chandrasekhar J; Kok MM; Kalkman DN; Aquino MB; Zocca P; Woudstra P; Beijk MA; Kerkmeijer LS; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Pocock S; von Birgelen C; Mehran R; de Winter RJ;
JACC Cardiovasc Interv; 2020 Apr; 13(7):820-830. PubMed ID: 32273094
[TBL] [Abstract][Full Text] [Related]
3. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration.
Chandrasekhar J; Zeebregts D; Kalkman DN; Sartori S; Roumeliotis A; Aquino MB; de Wilde P; de Winter VC; Baber U; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Lee M; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; de Winter RJ;
Cardiovasc Revasc Med; 2020 Dec; 21(12):1542-1547. PubMed ID: 32507695
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
de Winter RJ; Chandrasekhar J; Kalkman DN; Aquino MB; Woudstra P; Beijk MA; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; ;
JACC Cardiovasc Interv; 2018 Oct; 11(19):1969-1978. PubMed ID: 30286855
[TBL] [Abstract][Full Text] [Related]
5. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
Chandrasekhar J; Kerkmeijer LS; Kalkman DN; Sartori S; Aquino MB; Woudstra P; Beijk MA; Tijssen JG; Koch KT; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Munawar M; Gerber RT; Yan BP; Lee M; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Catheter Cardiovasc Interv; 2021 Apr; 97(5):797-804. PubMed ID: 32198837
[TBL] [Abstract][Full Text] [Related]
7. Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Kalkman DN; Kerkmeijer LS; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2019 Sep; 94(3):342-347. PubMed ID: 30565371
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
Colombo A; Chandrasekhar J; Aquino M; Ong TK; Sartori S; Baber U; Lee M; Iniguez A; Hajek P; Borisov B; Atzev B; Den Heijer P; Coufal Z; Hudec M; Mates M; Snyder C; Moalem K; Morrell D; Elmore F; Rowland S; Mehran R;
Int J Cardiol; 2019 May; 283():67-72. PubMed ID: 30826192
[TBL] [Abstract][Full Text] [Related]
9. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
Chandrasekhar J; de Winter VC; Kalkman DN; Sartori S; Chandiramani R; Aquino MB; de Wilde P; Zeebregts D; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Lee M; Tijssen JG; Koch KT; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Cardiovasc Drugs Ther; 2021 Apr; 35(2):309-320. PubMed ID: 33515411
[TBL] [Abstract][Full Text] [Related]
10. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
Nardin M; Pivato CA; Cao D; Sartori S; Zhang Z; Vogel B; Nicolas J; Chiarito M; Qiu H; Chandrasekhar J; Spirito A; Abizaid A; Christiansen EH; Colombo A; de Winter RJ; Haude M; Jakobsen L; Jensen LO; Krucoff MW; Landmesser U; Saito S; Suryapranata H; De Luca G; Dangas G; Mehran R
Int J Cardiol; 2023 Jan; 370():149-155. PubMed ID: 36270496
[TBL] [Abstract][Full Text] [Related]
11. One-year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration.
Chandrasekhar J; Kalkman DN; Sartori S; Baber U; Blum M; Aquino MB; Woudstra P; Beijk MA; Tijssen JG; Koch KT; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Catheter Cardiovasc Interv; 2020 Sep; ():. PubMed ID: 32964556
[TBL] [Abstract][Full Text] [Related]
12. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry).
Chandrasekhar J; Sartori S; Aquino MB; Baber U; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Khashaba A; Schee A; Munawar M; Gerber RT; Yan BP; Tejedor P; Kala P; Liew HB; Lee M; Kalkman DN; Dangas GD; de Winter RJ; Colombo A; Mehran R;
Am J Cardiol; 2020 Jul; 127():1-8. PubMed ID: 32418717
[TBL] [Abstract][Full Text] [Related]
13. Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent.
Kalkman DN; Woudstra P; Menown IBA; Tijssen JG; Beijk MAM; de Winter RJ;
Cardiovasc Revasc Med; 2018; 19(3 Pt B):373-375. PubMed ID: 29277288
[TBL] [Abstract][Full Text] [Related]
14. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
Beneduce A; Ferrante G; Ielasi A; Pivato CA; Chiarito M; Cappelletti A; Baldetti L; Magni V; Prati E; Falcone S; Pierri A; De Martini S; Montorfano M; Parisi R; Rutigliano D; Locuratolo N; Anzuini A; Tespili M; Margonato A; Benassi A; Briguori C; Reimers B; Fabbiocchi F; Bartorelli A; Colombo A; Godino C
Catheter Cardiovasc Interv; 2020 Aug; 96(2):255-265. PubMed ID: 31905259
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
Kerkmeijer LS; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; Van't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Cardiovasc Revasc Med; 2020 May; 21(5):567-570. PubMed ID: 31662276
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
17. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
18. One-year clinical results of the NANO registry: A multicenter, prospective all-comers registry study in patients receiving implantation of a polymer-free sirolimus-eluting stent.
Liu Y; Zhang Y; Li Y; Qi T; Pan D; Wang H; Liu C; Ma D; Fang Z; Zhang R; Mou F; Tao L;
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():658-664. PubMed ID: 31961057
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis.
Kalkman DN; Kok MM; van der Heijden LC; Woudstra P; Beijk MAM; Tijssen JGP; von Birgelen C; de Winter RJ
EuroIntervention; 2017 Nov; 13(10):1202-1209. PubMed ID: 28870878
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]